Additionally, lower USP3 mRNA expression predicted a worse prognosis not only for CRC patients, but also for patients with other malignancies, such as gastric cancer, lung cancer and breast cancer (Supplementary Fig. S6). This evidence concerns the gene USP3 and colorectal carcinoma.